Increased plasma homocysteine predicts arrhythmia recurrence after minimally invasive epicardial ablation for nonvalvular atrial fibrillation

Giuseppe Nasso, Raffaele Bonifazi, Vito Romano, Mario Siro Brigiani, Flavio Fiore, Francesco Bartolomucci, Mauro Lamarra, Khalil Fattouch, Giuseppe Rosano, Mario Gaudino, Roberta Spirito, Carlo Gaudio, Giuseppe Speziale

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: Minimally invasive epicardial ablation via right minithoracotomy is an emerging option for patients with drug-refractory nonvalvular atrial fibrillation. To guide the development of rational treatment algorithms, factors predisposing to recurrence of arrhythmia need to be quantified and eventually treated. We addressed the association of the plasma levels of homocysteine and the recurrence of atrial fibrillation after minimally invasive ablation. Methods: We obtained peripheral blood samples from 104 patients at follow-up after arrhythmia surgery; the homocysteine concentration was expressed as micromoles per liter. Prospective follow-up was conducted through electrocardiogram Holter monitoring (average 18.5 ± 5.8 months). Stratified analysis (high vs low homocysteine) was based on the cutoff value for the last quartile of homocysteine concentration (16 μmol/L). Time-to-event and diagnostic performance analyses were performed. Results: The rate of freedom from atrial fibrillation was 89.4% at the end of follow-up. Elevated circulating homocysteine level, persistent type of atrial fibrillation, and increased left atrial dimension independently predicted the recurrence of atrial fibrillation during the follow-up (adjusted Cox regression). Patients with a high homocysteine level were more likely to have atrial fibrillation recurrence (stratified Kaplan-Meier, P

Original languageEnglish
Pages (from-to)848-853
Number of pages6
JournalJournal of Thoracic and Cardiovascular Surgery
Volume146
Issue number4
DOIs
Publication statusPublished - Oct 2013

Fingerprint

Homocysteine
Atrial Fibrillation
Cardiac Arrhythmias
Recurrence
Ambulatory Electrocardiography
Causality
Electrocardiography
Pharmaceutical Preparations

Keywords

  • AF
  • area under the curve
  • atrial fibrillation
  • AUC
  • ECG
  • electrocardiogram
  • Hcy
  • homocysteine
  • radiofrequency
  • receiver operating characteristic
  • RF
  • ROC
  • TIA
  • transient ischemic attack

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Cite this

Increased plasma homocysteine predicts arrhythmia recurrence after minimally invasive epicardial ablation for nonvalvular atrial fibrillation. / Nasso, Giuseppe; Bonifazi, Raffaele; Romano, Vito; Brigiani, Mario Siro; Fiore, Flavio; Bartolomucci, Francesco; Lamarra, Mauro; Fattouch, Khalil; Rosano, Giuseppe; Gaudino, Mario; Spirito, Roberta; Gaudio, Carlo; Speziale, Giuseppe.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 146, No. 4, 10.2013, p. 848-853.

Research output: Contribution to journalArticle

Nasso, G, Bonifazi, R, Romano, V, Brigiani, MS, Fiore, F, Bartolomucci, F, Lamarra, M, Fattouch, K, Rosano, G, Gaudino, M, Spirito, R, Gaudio, C & Speziale, G 2013, 'Increased plasma homocysteine predicts arrhythmia recurrence after minimally invasive epicardial ablation for nonvalvular atrial fibrillation', Journal of Thoracic and Cardiovascular Surgery, vol. 146, no. 4, pp. 848-853. https://doi.org/10.1016/j.jtcvs.2012.07.099
Nasso, Giuseppe ; Bonifazi, Raffaele ; Romano, Vito ; Brigiani, Mario Siro ; Fiore, Flavio ; Bartolomucci, Francesco ; Lamarra, Mauro ; Fattouch, Khalil ; Rosano, Giuseppe ; Gaudino, Mario ; Spirito, Roberta ; Gaudio, Carlo ; Speziale, Giuseppe. / Increased plasma homocysteine predicts arrhythmia recurrence after minimally invasive epicardial ablation for nonvalvular atrial fibrillation. In: Journal of Thoracic and Cardiovascular Surgery. 2013 ; Vol. 146, No. 4. pp. 848-853.
@article{95fe7f4386674255b484cbe1897a660f,
title = "Increased plasma homocysteine predicts arrhythmia recurrence after minimally invasive epicardial ablation for nonvalvular atrial fibrillation",
abstract = "Objective: Minimally invasive epicardial ablation via right minithoracotomy is an emerging option for patients with drug-refractory nonvalvular atrial fibrillation. To guide the development of rational treatment algorithms, factors predisposing to recurrence of arrhythmia need to be quantified and eventually treated. We addressed the association of the plasma levels of homocysteine and the recurrence of atrial fibrillation after minimally invasive ablation. Methods: We obtained peripheral blood samples from 104 patients at follow-up after arrhythmia surgery; the homocysteine concentration was expressed as micromoles per liter. Prospective follow-up was conducted through electrocardiogram Holter monitoring (average 18.5 ± 5.8 months). Stratified analysis (high vs low homocysteine) was based on the cutoff value for the last quartile of homocysteine concentration (16 μmol/L). Time-to-event and diagnostic performance analyses were performed. Results: The rate of freedom from atrial fibrillation was 89.4{\%} at the end of follow-up. Elevated circulating homocysteine level, persistent type of atrial fibrillation, and increased left atrial dimension independently predicted the recurrence of atrial fibrillation during the follow-up (adjusted Cox regression). Patients with a high homocysteine level were more likely to have atrial fibrillation recurrence (stratified Kaplan-Meier, P",
keywords = "AF, area under the curve, atrial fibrillation, AUC, ECG, electrocardiogram, Hcy, homocysteine, radiofrequency, receiver operating characteristic, RF, ROC, TIA, transient ischemic attack",
author = "Giuseppe Nasso and Raffaele Bonifazi and Vito Romano and Brigiani, {Mario Siro} and Flavio Fiore and Francesco Bartolomucci and Mauro Lamarra and Khalil Fattouch and Giuseppe Rosano and Mario Gaudino and Roberta Spirito and Carlo Gaudio and Giuseppe Speziale",
year = "2013",
month = "10",
doi = "10.1016/j.jtcvs.2012.07.099",
language = "English",
volume = "146",
pages = "848--853",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Increased plasma homocysteine predicts arrhythmia recurrence after minimally invasive epicardial ablation for nonvalvular atrial fibrillation

AU - Nasso, Giuseppe

AU - Bonifazi, Raffaele

AU - Romano, Vito

AU - Brigiani, Mario Siro

AU - Fiore, Flavio

AU - Bartolomucci, Francesco

AU - Lamarra, Mauro

AU - Fattouch, Khalil

AU - Rosano, Giuseppe

AU - Gaudino, Mario

AU - Spirito, Roberta

AU - Gaudio, Carlo

AU - Speziale, Giuseppe

PY - 2013/10

Y1 - 2013/10

N2 - Objective: Minimally invasive epicardial ablation via right minithoracotomy is an emerging option for patients with drug-refractory nonvalvular atrial fibrillation. To guide the development of rational treatment algorithms, factors predisposing to recurrence of arrhythmia need to be quantified and eventually treated. We addressed the association of the plasma levels of homocysteine and the recurrence of atrial fibrillation after minimally invasive ablation. Methods: We obtained peripheral blood samples from 104 patients at follow-up after arrhythmia surgery; the homocysteine concentration was expressed as micromoles per liter. Prospective follow-up was conducted through electrocardiogram Holter monitoring (average 18.5 ± 5.8 months). Stratified analysis (high vs low homocysteine) was based on the cutoff value for the last quartile of homocysteine concentration (16 μmol/L). Time-to-event and diagnostic performance analyses were performed. Results: The rate of freedom from atrial fibrillation was 89.4% at the end of follow-up. Elevated circulating homocysteine level, persistent type of atrial fibrillation, and increased left atrial dimension independently predicted the recurrence of atrial fibrillation during the follow-up (adjusted Cox regression). Patients with a high homocysteine level were more likely to have atrial fibrillation recurrence (stratified Kaplan-Meier, P

AB - Objective: Minimally invasive epicardial ablation via right minithoracotomy is an emerging option for patients with drug-refractory nonvalvular atrial fibrillation. To guide the development of rational treatment algorithms, factors predisposing to recurrence of arrhythmia need to be quantified and eventually treated. We addressed the association of the plasma levels of homocysteine and the recurrence of atrial fibrillation after minimally invasive ablation. Methods: We obtained peripheral blood samples from 104 patients at follow-up after arrhythmia surgery; the homocysteine concentration was expressed as micromoles per liter. Prospective follow-up was conducted through electrocardiogram Holter monitoring (average 18.5 ± 5.8 months). Stratified analysis (high vs low homocysteine) was based on the cutoff value for the last quartile of homocysteine concentration (16 μmol/L). Time-to-event and diagnostic performance analyses were performed. Results: The rate of freedom from atrial fibrillation was 89.4% at the end of follow-up. Elevated circulating homocysteine level, persistent type of atrial fibrillation, and increased left atrial dimension independently predicted the recurrence of atrial fibrillation during the follow-up (adjusted Cox regression). Patients with a high homocysteine level were more likely to have atrial fibrillation recurrence (stratified Kaplan-Meier, P

KW - AF

KW - area under the curve

KW - atrial fibrillation

KW - AUC

KW - ECG

KW - electrocardiogram

KW - Hcy

KW - homocysteine

KW - radiofrequency

KW - receiver operating characteristic

KW - RF

KW - ROC

KW - TIA

KW - transient ischemic attack

UR - http://www.scopus.com/inward/record.url?scp=84884412895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884412895&partnerID=8YFLogxK

U2 - 10.1016/j.jtcvs.2012.07.099

DO - 10.1016/j.jtcvs.2012.07.099

M3 - Article

VL - 146

SP - 848

EP - 853

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 4

ER -